Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae
Fructus Schizandrae (FS) is commonly used as a tonic in traditional Chinese medicine. Recently, FS was found to significantly improve liver dysfunction in chronic hepatitis patients. The present study was to assess the reversal effect of five schizandrins and crude extract from FS (named LCC) on multidrug resistance (MDR) of cancer cells, both in vitro and in vivo. Chemically, the five schizandins are derivatives of dibenzo-(a, c)-cyclooctene lignan with distinct structures differing from any known MDR reversal agents.
A panel of sensitive and resistant cancer cell lines were treated with various concentrations of LCC and schizandrins. Drug sensitivity, accumulation of Doxorubicin (Dox), expression of P-glycoprotein and protein kinase C (PKC), and apoptosis were determined in vitro. The in vivo effect was tested in nude mice grafted with sensitive and resistant human epidermal cancer cell line to vincristine (VCR) (KB, KBv200).
The tested five compounds at 25 μM showed various levels of MDR reversal activity, of which, schizandrin A (Sin A) was the most potent one. Sin A reversed VCR resistance in KBv200 cells, MCF-7/Dox cells and Bel7402 cells by 309-, 38-, and 84-folds, respectively. Also, Sin A reversed the resistance of Dox in the above cancer cell lines. LCC at 25 μg/ml reversed VCR resistance by 619-folds in KBv200, 181-folds in MCF-7/Dox cell line, and 1,563-folds in innate resistance of human hepatic cellular carcinoma Bel7402 cells to VCR. Furthermore, LCC and its active component Sin A potently reversed the cross-resistance to paclitaxel in those cell lines. Both Sin A and LCC markedly increased intracellular Dox accumulation and enhanced apoptosis, down-regulated Pgp protein and mRNA and total PKC expression in MDR cells. Coadministration of LCC (p.o.) significantly potentiated the inhibitory effect of VCR (i.p.) on tumor growth in nude mice bearing KBv200 xenograft.
The LCC and its active component Sin A have remarkable reversal effect on MDR in cancer cells by inhibition of both the function and expression of Pgp and total PKC.
KeywordsMultidrug resistance Pgp Fructus Schizandrae Schizandrins
- Sin A
- Sin B
- Sin C
- Sol A
- Sol B
Crude extract of Fructus Schizandrae
Protein kinase C
- Rho 123
Nitroblue tetrazolium chloride
This work was supported by the Natural Science Foundation of China (No. 30630069).
- 12.Lelong-Rebel IH, Cardarelli CO, Hardy SP, Valverde MA, Goodfellow HR, Higgins CF, Sepulveda FV (2005) Differential phosphorylation patterns of P-glycoprotein reconstituted into a proteoliposome system: insight into additional unconventional phosphorylation sites. Anticancer Res 25:3925–3935PubMedGoogle Scholar
- 14.Beck JF, Brugger D, Brischwein K, Liu C, Bader P, Niethammer D, Gekeler V (2001) Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblast cell line CCRF-CEM and in blasts from patients with acute lymphoblast leukemias. Jpn J Cancer Res 92:896–903PubMedGoogle Scholar
- 16.Liu GT (1989) Pharmacological actions and clinical use of Fructus Schizandrae. Chin Med J (Engl) 102:740–749Google Scholar
- 17.Liu GT, Wang GF, Wei HL, Bao TT, Song ZY (1979) A comparison of the protective actions of biphenyl dimethyl-dicarboxylate, transtilbene, alcoholic extracts of Fructus Schizandrae and ganoderma against experimental liver injury in mice. Acta Pharmacol Sin 1:598–604Google Scholar
- 20.Liu KT, Lesca P (1982) Pharmacological properties of dibenzo [a, c] cyclooctene derivatives isolated from Fructus Schizandrae chinensis. I. Interaction with rat liver cytochrome P-450 and inhibition of xenobiotics metabolism and mutagenicity. Chem Biol Interact 39:301–314PubMedCrossRefGoogle Scholar
- 22.Chen YY, Shu ZB, Li NL (1976) Studies on Fructus Schisandrae. IV. Isolation and determination of the active components (in lowering high serum ALT levels) of Fructus Schisandrae Sinensis Baill. Sci Sin XIX(1):278–280Google Scholar
- 23.Chen YY, Yang YC (1982) Studies on the serum ALT-lowering active component of the Fructus Schisandrae Rubriflora Rhed et Wils. Acta Pharmacol Sin 17:312–315Google Scholar
- 30.Bonsing BA, Corver WE, Gorsira MC, van Vliet M, Oud PS, Cornelisse CJ, Fleuren GJ (1997) Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry. Cytometry 28:11–24PubMedCrossRefGoogle Scholar